We found that parthenolide treatment of glioblastoma cells significantly attenuates VEGF and MMP-9 mRNA expression (Figure7A) and reduces the secretion of VEGF and MMP-9 protein into the culture medium (Figure7B; *, p < 0.0001). The gene discussed is VEGFA; the disease is glioblastoma.